Fidelity International’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$111K Buy
24,011
+3,587
+18% +$17.8K ﹤0.01% 1073
2026
Q1
$94.6K Buy
20,424
+2,248
+12% +$11.7K ﹤0.01% 1019
2025
Q4
$90.9K Sell
18,176
-27,427
-60% -$143K ﹤0.01% 969
2025
Q3
$231K Buy
45,603
+3,190
+8% +$14.1K ﹤0.01% 861
2025
Q2
$183K Sell
42,413
-10,810
-20% -$53.4K ﹤0.01% 868
2025
Q1
$321K Buy
53,223
+32,780
+160% +$166K ﹤0.01% 813
2024
Q4
$80.8K Sell
20,443
-2,231
-10% -$9.99K ﹤0.01% 854
2024
Q3
$133K Sell
22,674
-3,735
-14% -$18.4K ﹤0.01% 834
2024
Q2
$114K Buy
+26,409
New +$127K ﹤0.01% 834
2023
Q1
Sell
-119,633
Closed -$1.33M 841
2022
Q4
$1.33M Buy
119,633
+33,536
+39% +$390K ﹤0.01% 690
2022
Q3
$1.02M Buy
+86,097
New +$1.3M ﹤0.01% 709

Other funds holding MPT

Fidelity International's MPT Position: Q2 2026 in Review

Fidelity International increased its Medical Properties Trust (MPT) stake by 18% in Q2 2026, buying an estimated $17.8K and bringing the position to 24,011 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #1073.

Fidelity International first reported a position in MPT in Q3 2022 and has held it in 11 quarters since. The position peaked at $1.33M in Q4 2022. 398 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • Fidelity International held 24,011 shares of Medical Properties Trust worth $111K as of Q2 2026.
  • Fidelity International bought 3,587 Medical Properties Trust shares in Q2 2026, an estimated $17.8K.
  • Medical Properties Trust made up ﹤0.01% of Fidelity International's portfolio in Q2 2026, its #1073 holding.
  • Fidelity International first reported a position in Medical Properties Trust in Q3 2022 and has held it in 11 quarters since.
  • Fidelity International's Medical Properties Trust position peaked at $1.33M in Q4 2022.
  • 398 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.